You are here: Industry Insights > UK

News List

Merck, Ridgeback to supply 1.75 million molnupiravir courses to UK Pharmaceutical-Business-Review
December 24, 2021
Molnupiravir is an orally administered form of a potent ribonucleoside analogue that blocks the SARS-CoV-2 replication. It is planned to be sold under the trademark Lagevrio in the UK.
UK trial to assess Sativex for the treatment of ‘aggressive’ brain tumours pharmatimes
August 06, 2021
A new UK-based trial is set to assess the efficacy of GW Pharma’s cannabis-based drug Sativex as a potential treatment for patients with a recurrent glioblastoma – the most aggressive form of brain tumours.
More than 85 million COVID vaccines administered across the UK, reports DHSC pharmatimes
August 03, 2021
A total of 85,196,986 doses of a COVID-19 vaccine have been administered in the UK according to the latest figures, with 46,851,145 people receiving a first dose (88.6%) and 38,345,841 people receiving both doses (72.5%).
India and UK to conduct clinical trials of Ashwagandha for promoting COVID-19 recovery expresspharma
August 03, 2021
MoU signed between All India Institute of Ayurveda (under the Ministry of Ayush) and the UK’s London School of Hygiene and Tropical Medicine.
GPs call for rescue plan to ‘save’ general practice in the UK pharmatimes
August 02, 2021
The Royal College of General Practitioners (RCGP) has called for an emergency rescue package to provide a solution to ‘crisis-torn’ general practice in the UK.
UK genomics market valued at over £5bn, according to new report pharmatimes
August 02, 2021
A new report has revealed the strength of the UK’s genomics sector for investors, patients and the UK economy, adding that the sector has a market of over £5bn.
New study provides insight into the pharma industry’s reputation in the UK pharmatimes
July 30, 2021
New research from the Association of the British Pharmaceutical Industry (ABPI) and Ipsos MORI reveals attitudes to the pharmaceutical industry in the UK, including perceptions of healthcare professionals (HCPs), the public and members of parliament.
High Commissioner of India visits Wockhardt UK expresspharma
July 29, 2021
The High Commissioner was provided with a tour of the vaccine fill-finish facility which is currently contracted by the UK Government to manufacture the Oxford/AstraZeneca COVID-19 vaccine until August 2022.
UK to launch research studies to develop long Covid therapies pharmaceutical-technology
July 20, 2021
The UK Government has announced plans to commence a research programme comprising of 15 new studies to develop new therapies for long Covid and enhance diagnosis.
‘Most comprehensive’ flu vaccination programme in UK history launching for winter 2021 pharmatimes
July 19, 2021
The government has announced that it will launch the ‘most comprehensive’ flu vaccination programme in UK history for winter 2021.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page